Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 9,640 shares of the firm’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $4.39, for a total value of $42,319.60. Following the completion of the transaction, the chief executive officer owned 113,850 shares of the company’s stock, valued at approximately $499,801.50. This represents a 7.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Amit Gupta also recently made the following trade(s):
- On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total transaction of $28,526.22.
Cardlytics Trading Down 5.9%
NASDAQ:CDLX opened at $4.01 on Thursday. The firm has a 50-day moving average price of $6.06 and a two-hundred day moving average price of $8.62. Cardlytics, Inc. has a twelve month low of $3.95 and a twelve month high of $32.80. The company has a market capitalization of $23.30 million, a P/E ratio of -0.23 and a beta of 0.61.
Analyst Ratings Changes
Check Out Our Latest Report on CDLX
Hedge Funds Weigh In On Cardlytics
Several institutional investors and hedge funds have recently modified their holdings of CDLX. Bank of America Corp DE grew its stake in Cardlytics by 262.7% in the 3rd quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock worth $3,968,000 after acquiring an additional 1,182,593 shares during the period. Quinn Opportunity Partners LLC lifted its stake in shares of Cardlytics by 900.0% during the 3rd quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after purchasing an additional 990,000 shares during the period. UBS Group AG lifted its stake in shares of Cardlytics by 112.5% during the 3rd quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after purchasing an additional 242,536 shares during the period. Raymond James Financial Inc. boosted its holdings in shares of Cardlytics by 36,915.3% during the third quarter. Raymond James Financial Inc. now owns 133,255 shares of the company’s stock worth $324,000 after purchasing an additional 132,895 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in shares of Cardlytics by 263.0% during the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock worth $267,000 after purchasing an additional 117,687 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Further Reading
- Five stocks we like better than Cardlytics
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
